The safety of immunizing with tetanus–diphtheria–acellular pertussis vaccine (Tdap) less than 2 years following previous tetanus vaccination: experience during a …
EA Talbot, KH Brown, KB Kirkland, AL Baughman… - Vaccine, 2010 - Elsevier
BACKGROUND: Tdap is recommended for health care personnel (HCP) aged< 65 years
who received tetanus diphtheria or tetanus toxoid immunization (Td/TT)≥ 2 years earlier …
who received tetanus diphtheria or tetanus toxoid immunization (Td/TT)≥ 2 years earlier …
[HTML][HTML] The effectiveness and safety of pertussis booster vaccination for adolescents and adults: A systematic review and meta-analysis
J Xu, S Liu, Q Liu, R Rong, W Tang, Q Wang, S Kuang… - Medicine, 2019 - journals.lww.com
Background: Due to the resurgence of pertussis, many countries have revised the pertussis
immunization schedules and recommended booster doses of pertussis component vaccine …
immunization schedules and recommended booster doses of pertussis component vaccine …
[HTML][HTML] Antibody persistence following administration of a hexavalent DTwP-IPV-HB-PRP∼ T vaccine versus separate DTwP-HB-PRP∼ T and IPV vaccines at 12–24 …
Background The combination of whole-cell pertussis (wP) antigens with established
diphtheria (D), tetanus (T), hepatitis B (HB), Haemophilus influenzae type b (Hib), and …
diphtheria (D), tetanus (T), hepatitis B (HB), Haemophilus influenzae type b (Hib), and …
[HTML][HTML] Safety and reactogenicity of a low-dose diphtheria-tetanus-acellular pertussis vaccine (BoostrixTM) in pre-school Indian children
A Bose, AP Dubey, D Gandhi, A Pandit… - Indian …, 2007 - indianpediatrics.net
Objective: To evaluate the safety and reactogenicity of a reduced-antigen-content combined
Diphtheria-Tetanus-Acellular Pertussis (dTpa) vaccine in Indian pre-school children …
Diphtheria-Tetanus-Acellular Pertussis (dTpa) vaccine in Indian pre-school children …
Immunogenicity and safety following primary and booster vaccination with a hexavalent diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated poliovirus and …
NP Klein, R Abu-Elyazeed, B Cheuvart… - Human Vaccines & …, 2019 - Taylor & Francis
Combined hexavalent diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated
poliomyelitis and Haemophilus influenzae type b vaccine (DTaP-HBV-IPV/Hib) can further …
poliomyelitis and Haemophilus influenzae type b vaccine (DTaP-HBV-IPV/Hib) can further …
Immunogenicity of a single dose of reduced-antigen acellular pertussis vaccine in a non-vaccinated adolescent population
M Knuf, F Zepp, C Meyer, E Grzegowski, J Wolter… - Vaccine, 2006 - Elsevier
German adolescents (n= 123) without previous pertussis vaccination, no history of pertussis
and low IgG-anti-pertussis-toxin (PT) levels received one dose of the Tdap vaccine …
and low IgG-anti-pertussis-toxin (PT) levels received one dose of the Tdap vaccine …
Immunogenicity and safety after booster vaccination of diphtheria, tetanus, and acellular pertussis in young adults: an open randomized controlled trial in Japan
M Hara, K Okada, Y Yamaguchi, S Uno… - Clinical and Vaccine …, 2013 - Am Soc Microbiol
The recent increase of pertussis in young adults in Japan is hypothesized to be due in part
to waning protection from the acellular pertussis vaccine. While a booster immunization may …
to waning protection from the acellular pertussis vaccine. While a booster immunization may …
Safety and immunogenicity of a diphtheria, tetanus, acellular pertussis and Haemophilus influenzae Type b combination vaccine compared with separate …
G Li, H Zhang, W Zhou, Q Ye, F Li, H Wang, Q Hou… - Vaccine, 2010 - Elsevier
To evaluate the safety and immunogenicity of a diphtheria, tetanus, acellular pertussis and
Haemophilus infuenzae Type b (DTaP/Hib) combination vaccine first developed by a …
Haemophilus infuenzae Type b (DTaP/Hib) combination vaccine first developed by a …
Combined tetanus, diphtheria, and 5-component pertussis vaccine for use in adolescents and adults
ME Pichichero, MB Rennels, KM Edwards, MM Blatter… - Jama, 2005 - jamanetwork.com
ContextIncreasing reports of pertussis among US adolescents, adults, and their infant
contacts have stimulated vaccine development for older age groups. ObjectiveTo assess the …
contacts have stimulated vaccine development for older age groups. ObjectiveTo assess the …
Safety of Tdap-IPV given one month after Td-IPV booster in healthy young adults: a placebo-controlled trial
J Beytout, O Launay, N Guiso, A Fiquet, M Baudin… - Human …, 2009 - Taylor & Francis
Background: In France, the only vaccines available for use as a pertussis booster in adults
are combined vaccines containing adsorbed tetanus, diphtheria (adult formulation), acellular …
are combined vaccines containing adsorbed tetanus, diphtheria (adult formulation), acellular …